Serum Bactericidal Activity Against Helicobacter Pylori in Patients with Hypogammaglobulinaemia

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2009 May 15

PMID 19438595

Citations 14

Authors

I M E Desar

M van Deuren

T Sprong

J B M J Jansen

F Namavar

C M Vandenbroucke-Grauls

J W M van der Meer

Affiliations

Soon will be listed here.

Abstract

The two major primary antibody deficiency disorders are X-linked hypogammaglobulinaemia (XLA) and common variable immunodeficiency (CVID). CVID patients have an elevated risk for gastric cancer and extra-nodal marginal zone lymphoma. Both diseases are associated with Helicobacter pylori infection. We investigated whether antibody deficiency leads to defective serum bactericidal activity against H. pylori. We also investigated the correlation with immunoglobulin (Ig)M levels and observed the terminal complement complex (TCC) activity. Sera of 13 CVID patients (four H. pylori positive), one patient with hyper-IgM syndrome, one patient with Good syndrome (both H. pylori positive), five XLA patients, four H. pylori seropositive controls, four H. pylori seronegative controls and a sample of pooled human serum (PHS) were incubated in vitro with bacterial suspensions of H. pylori for 30 min. After 72 h of culture, colony-forming units were counted. TCC formation was measured by enzyme-linked immunosorbent assay. We found that normal human serum is bactericidal for H. pylori, whereas heat-inactivated serum shows hardly any killing of H. pylori. Serum (1%) of hypogammaglobulinaemia patients has a decreased bactericidal activity against H. pylori. Helicobacter pylori-positive (HP(+)) normal individuals show more than 90% killing of H. pylori, whereas CVID patients show 35% killing (P = 0.007) and XLA patients only 19% (P = 0.003). Serum (1%) of HP(+) volunteers showed significantly better killing compared with serum of H. pylori-negative (HP(-)) volunteers (P = 0.034). No correlation between (substituted) IgG levels and serum bactericidal activity was found, but a weak correlation between total serum IgM and serum bactericidal activity was found. In conclusion, serum bactericidal activity against H. pylori is decreased in patients with hypogammaglobulinaemia. Heat treatment of the serum abolished the bactericidal capacity, indicating that complement activity is essential for the bactericidal effect.

Citing Articles

Impact of Vitamin D Levels on Clinical Outcomes in SARS-CoV-2 Infections.

Najih M, Boussettine R, El Kehel M, Nabil K, Azmi H, Berradi H Cureus. 2025; 17(1):e78291.

PMID: 40026986 PMC: 11872144. DOI: 10.7759/cureus.78291.

Expanding the Clinical Phenotype with CD79A Mutation and Refractory Helicobacter Bilis Infection.

Sil A, Basu S, Arora K, Khubchandani R, Rawat A, Suri D J Clin Immunol. 2024; 44(8):187.

PMID: 39215847 DOI: 10.1007/s10875-024-01792-9.

Real-World Case Series of Efgartigimod for Japanese Generalized Myasthenia Gravis: Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom Control.

Konno S, Uchi T, Kihara H, Sugimoto H Biomedicines. 2024; 12(6).

PMID: 38927421 PMC: 11200869. DOI: 10.3390/biomedicines12061214.

Young Patient with X-linked Agammaglobulinemia Presents with Advanced Gastric Cancer and Extensive Atrophic Gastritis.

Kon T, Sasaki Y, Abe Y, Yagi M, Mizumoto N, Onozato Y Intern Med. 2024; 64(1):95-100.

PMID: 38749732 PMC: 11781919. DOI: 10.2169/internalmedicine.3236-23.

Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model.

Ying L, Liu P, Ding Z, Wray-McCann G, Emery J, Colon N J Pathol. 2023; 259(4):402-414.

PMID: 36640261 PMC: 10952994. DOI: 10.1002/path.6053.

References

Stagg A, Funauchi M, Knight S, Webster A, Farrant J . Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 1994; 96(1):48-53. PMC: 1534526. DOI: 10.1111/j.1365-2249.1994.tb06228.x. View

van der Meer J, Weening R, Schellekens P, van Munster I, Nagengast F . Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet. 1993; 341(8858):1439-40. DOI: 10.1016/0140-6736(93)90883-i. View

Park M, Li J, Hagan J, Maddox D, Abraham R . Common variable immunodeficiency: a new look at an old disease. Lancet. 2008; 372(9637):489-502. DOI: 10.1016/S0140-6736(08)61199-X. View

Wright J, Wagner D, Blaese R, Hagengruber C, Waldmann T, Fleisher T . Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood. 1990; 76(10):2046-51. View

Cunningham-Rundles C, Bodian C . Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999; 92(1):34-48. DOI: 10.1006/clim.1999.4725. View

Tsukada S, Saffran D, Rawlings D, Parolini O, Allen R, Klisak I . Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993; 72(2):279-90. DOI: 10.1016/0092-8674(93)90667-f. View

Sprong T, Brandtzaeg P, Fung M, Pharo A, Hoiby E, Michaelsen T . Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood. 2003; 102(10):3702-10. DOI: 10.1182/blood-2003-03-0703. View

Desar I, Keuter M, Raemaekers J, J B M J Jansen , Van Krieken J, van der Meer J . Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency. Neth J Med. 2006; 64(5):136-40. View

Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F . Gastric pathology in patients with common variable immunodeficiency. Gut. 1999; 45(1):77-81. PMC: 1727591. DOI: 10.1136/gut.45.1.77. View

10.

Gonzalez-Valencia G, Perez-Perez G, Washburn R, Blaser M . Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter. 1996; 1(1):28-33. DOI: 10.1111/j.1523-5378.1996.tb00005.x. View

11.

Desar I, Weemaes C, van Deuren M, van der Meer J . Reversible hypogammaglobulinaemia. Neth J Med. 2007; 65(10):381-5. View

12.

Kerstens P, Endtz H, Meis J, Oyen W, Koopman R, van den Broek P . Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis. 1992; 11(9):842-7. DOI: 10.1007/BF01960888. View

13.

. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet. 1993; 341(8857):1359-62. View

14.

Teahon K, Webster A, Price A, Weston J, Bjarnason I . Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut. 1994; 35(9):1244-9. PMC: 1375701. DOI: 10.1136/gut.35.9.1244. View

15.

Cunningham-Rundles S, Cunningham-Rundles C, Siegal F, Gupta S, Smithwick E, Kosloff C . Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol. 1981; 1(1):65-72. DOI: 10.1007/BF00915478. View

16.

Kondratenko I, Amlot P, Webster A, Farrant J . Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group. Clin Exp Immunol. 1997; 108(1):9-13. PMC: 1904616. DOI: 10.1046/j.1365-2249.1997.d01-993.x. View

17.

. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994; 61:1-241. PMC: 7681621. View

18.

Drogari-Apiranthitou M, Kuijper E, Dekker N, Dankert J . Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity. Infect Immun. 2002; 70(7):3752-8. PMC: 128098. DOI: 10.1128/IAI.70.7.3752-3758.2002. View

19.

Kinlen L, Webster A, Bird A, Haile R, Peto J, Soothill J . Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985; 1(8423):263-6. DOI: 10.1016/s0140-6736(85)91037-2. View

20.

Cunningham-Rundles C, Cooper D, Duffy T, Strauchen J . Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol. 2002; 69(3):171-8. DOI: 10.1002/ajh.10050. View